Melanoma
News
Patient’s Own Immune Cells Help Attack Melanoma
(06/20/2008)
Results from one patient involved in a clinical trial have demonstrated that a complete regression of advanced melanoma may occur with the use of a patient’s own immune cells.
Nexavar® Shows Promise for the Treatment of Advanced Melanoma
(05/08/2008)
Researchers from the United States have recently reported that, among patients with advanced melanoma, the addition to chemotherapy of the drug Nexavar® (sorafenib) improved progression-free survival. Full details of the study were published in the Journal of Clinical Oncology.
Gleevec® May Be Effective for Some Patients with Metastatic Melanoma
(04/29/2008)
The targeted agent Gleevec® (imatinib) may be a promising therapy for some patients with metastatic melanoma. These results were recently presented at the 2008 annual meeting of the American Association for Cancer Research.
Patients Undergoing Organ Transplant at Increased Risk for Skin Cancer
(04/30/2008)
Patients who receive an organ transplant are at an increased risk for developing various types of cancer, including skin cancers. It recommended that these patients receive extensive education about risks of skin cancer as well as screening measures. These results were recently presented at the 2008 annual meeting of the American Academy of Dermatology.
Tanning Beds Pose Skin Cancer Risks
(04/28/2008)
Despite marketing efforts by the tanning bed industry that use of tanning beds can provide the healthful benefit of increasing vitamin D levels, researchers claim that “there is absolutely no justification for indoor tanning,” citing the associated risk of skin cancer and the availability of vitamin D from sources other than UV exposure. These results were presented at the 2008 annual meeting of the American Academy of Dermatology.
More
Melanoma
Cancer News...